Nanosuspensions - An Update on Recent Patents, Methods of Preparation, and Evaluation Parameters.
Khanuja, HK
Awasthi, R
Mehta, M
Satija, S
Aljabali, AA
Tambuwala, MM
Chellappan, DK
Dua, K
Dureja, H
- Publisher:
- Bentham Science Publishers Ltd.
- Publication Type:
- Journal Article
- Citation:
- Recent patents on nanotechnology, 2021, 15, (4), pp. 351-366
- Issue Date:
- 2021-01-01
Closed Access
Filename | Description | Size | |||
---|---|---|---|---|---|
Dureja (45) MS-Proof Nanosuspension (1).pdf | Published version | 706.62 kB | Adobe PDF |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Khanuja, HK | |
dc.contributor.author | Awasthi, R | |
dc.contributor.author | Mehta, M | |
dc.contributor.author | Satija, S | |
dc.contributor.author | Aljabali, AA | |
dc.contributor.author | Tambuwala, MM | |
dc.contributor.author | Chellappan, DK | |
dc.contributor.author |
Dua, K https://orcid.org/0000-0002-7507-1159 |
|
dc.contributor.author | Dureja, H | |
dc.date.accessioned | 2022-06-17T02:05:52Z | |
dc.date.available | 2020-11-06 | |
dc.date.available | 2022-06-17T02:05:52Z | |
dc.date.issued | 2021-01-01 | |
dc.identifier.citation | Recent patents on nanotechnology, 2021, 15, (4), pp. 351-366 | |
dc.identifier.issn | 1872-2105 | |
dc.identifier.issn | 2212-4020 | |
dc.identifier.uri | http://hdl.handle.net/10453/158222 | |
dc.description.abstract | <h4>Background</h4>Nanosuspensions are colloidal systems consisting of pure drug and stabilizers, without matrix or lyophilized into a solid matrix. Nanosuspensions improve the solubility of the drug both in the aqueous and organic phases. Nanosuspensions are also known as brick dust molecules, as they increase the dissolution of a system and improve absorption.<h4>Methods</h4>Extensive information related to nanosuspensions and its associated patents were collected using PubMed and Google Scholar.<h4>Results</h4>Over the last decade nanosuspensions have attracted tremendous interest in pharmaceutical research. It provides unique features including, improved solubility, high drug loading capacity, and passive targeting. These particles are costeffective, simple, and have lesser side effects with minimal dose requirements. However, the stability of nanosuspensions still warrants attention.<h4>Conclusion</h4>Nanosuspensions plays a vital role in handling the numerous drug entities with difficult physico-chemical characteristics such as solubility and can further aid with a range of routes that include nasal, transdermal, occular, parenteral, pulmonary etc. This review highlights the relevance of nanosuspensions in achieving safe, effective and targeted drug delivery. | |
dc.format | Print-Electronic | |
dc.language | eng | |
dc.publisher | Bentham Science Publishers Ltd. | |
dc.relation.ispartof | Recent patents on nanotechnology | |
dc.relation.isbasedon | 10.2174/1872210514666201224103010 | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | 0910 Manufacturing Engineering, 1007 Nanotechnology | |
dc.subject.classification | Nanoscience & Nanotechnology | |
dc.subject.mesh | Administration, Cutaneous | |
dc.subject.mesh | Drug-Related Side Effects and Adverse Reactions | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Nanoparticles | |
dc.subject.mesh | Particle Size | |
dc.subject.mesh | Patents as Topic | |
dc.subject.mesh | Solubility | |
dc.subject.mesh | Suspensions | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Suspensions | |
dc.subject.mesh | Administration, Cutaneous | |
dc.subject.mesh | Particle Size | |
dc.subject.mesh | Solubility | |
dc.subject.mesh | Nanoparticles | |
dc.subject.mesh | Patents as Topic | |
dc.subject.mesh | Drug-Related Side Effects and Adverse Reactions | |
dc.title | Nanosuspensions - An Update on Recent Patents, Methods of Preparation, and Evaluation Parameters. | |
dc.type | Journal Article | |
utslib.citation.volume | 15 | |
utslib.location.activity | United Arab Emirates | |
utslib.for | 0910 Manufacturing Engineering | |
utslib.for | 1007 Nanotechnology | |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Health | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Health/Graduate School of Health | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Health/Graduate School of Health/GSH.Pharmacy | |
utslib.copyright.status | closed_access | * |
pubs.consider-herdc | false | |
dc.date.updated | 2022-06-17T02:05:50Z | |
pubs.issue | 4 | |
pubs.publication-status | Published | |
pubs.volume | 15 | |
utslib.citation.issue | 4 |
Abstract:
Background
Nanosuspensions are colloidal systems consisting of pure drug and stabilizers, without matrix or lyophilized into a solid matrix. Nanosuspensions improve the solubility of the drug both in the aqueous and organic phases. Nanosuspensions are also known as brick dust molecules, as they increase the dissolution of a system and improve absorption.Methods
Extensive information related to nanosuspensions and its associated patents were collected using PubMed and Google Scholar.Results
Over the last decade nanosuspensions have attracted tremendous interest in pharmaceutical research. It provides unique features including, improved solubility, high drug loading capacity, and passive targeting. These particles are costeffective, simple, and have lesser side effects with minimal dose requirements. However, the stability of nanosuspensions still warrants attention.Conclusion
Nanosuspensions plays a vital role in handling the numerous drug entities with difficult physico-chemical characteristics such as solubility and can further aid with a range of routes that include nasal, transdermal, occular, parenteral, pulmonary etc. This review highlights the relevance of nanosuspensions in achieving safe, effective and targeted drug delivery.Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph